KEYNOTE-177: Phase III randomized study of pembrolizumab versus chemotherapy for microsatellite instability-high advanced colorectal cancer Meeting Abstract


Authors: Shiu, K. K.; Andre, T.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D. M.; Garcia-Carbonero, R.; Benavides, M.; Gibbs, P.; De La Fouchardiere, C.; Rivera, F.; Elez, E.; Bendell, J. C.; Le, D. T.; Yoshino, T.; Yang, P.; Farooqui, M. Z. H.; Marinello, P.; Diaz, L. A.
Abstract Title: KEYNOTE-177: Phase III randomized study of pembrolizumab versus chemotherapy for microsatellite instability-high advanced colorectal cancer
Meeting Title: 2021 Gastrointestinal Cancers Symposium (ASCO GI)
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 3 Suppl.
Meeting Dates: 2021 Jan 15-17
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-01-20
Language: English
ACCESSION: WOS:000636712800062
DOI: 10.1200/JCO.2021.39.3_suppl.6
PROVIDER: wos
Notes: Meeting Abstract: 6 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Luis Alberto Diaz
    148 Diaz